A naturalistic study of the association between antidepressant treatment and outcome of smoking cessation treatment

Journal of Clinical Psychiatry

Volumn 75, Issue 12, 2014, Pages e1433-e1438

  Zorick, Todd ^a,b   Mandelkern, Mark A ^c   Brody, Arthur L ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBON MONOXIDE; MOOD STABILIZER; NICOTINE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BREATH ANALYSIS; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; NATURALISTIC INQUIRY; NICOTINE REPLACEMENT THERAPY; OUTPATIENT CARE; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; COGNITIVE THERAPY; COMPLICATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84925229112     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09012     Document Type: Article

References (24)

1. Giovino GA, Mirza SA, Samet JM, et al GATS Collaborative Group. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012;380(9842):668-679. doi:10.1016/S0140-6736(12)61085-X PubMed
2. US Centers for Disease Control and Prevention. Health effect of cigarette smoking. Smoking and tobacco use 2013; August 1, 2013. http://www.cdc. gov/tobacco/data-statistics/fact-sheets/health-effects/effects-cig-smoking/ index.htm. Updated February 6, 2014. Accessed October 9, 2013.
3. Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2012;10:CD008286. PubMed
4. Gershon Grand RB, Hwang S, Han J, et al. Short-term naturalistic treatment outcomes in cigarette smokers with substance abuse and/or mental illness. J Clin Psychiatry. 2007;68(6):892-898, quiz 980-981. doi:10.4088/JCP.v68n0611 PubMed
5. Mackowick KM, Lynch MJ, Weinberger AH, et al. Treatment of tobacco dependence in people with mental health and addictive disorders. Curr Psychiatry Rep. 2012;14(5):478-485. doi:10.1007/s11920-012-0299-2 PubMed
6. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606-2610. doi:10.1001/jama.284.20.2606 PubMed
7. Ziedonis D, Hitsman B, Beckham JC, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008;10(12):1691-1715. doi:10.1080/14622200802443569 PubMed
8. Hitsman B, Papandonatos GD, McChargue DE, et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction. 2013;108(2):294-306. doi:10.1111/add.12009 PubMed
9. van der Meer RM, Willemsen MC, Smit F, et al. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013;8:CD006102. PubMed
10. Gravely-Witte S, Stewart DE, Suskin N, et al. The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients. J Behav Med. 2009;32(5):478-490. doi:10.1007/s10865-009-9218-3 PubMed
11. Stolz D, Scherr A, Seiffert B, et al. Predictors of success for smoking cessation at the workplace: a longitudinal study. Respiration. 2014;87(1):18-25. doi:10.1159/000346646 PubMed
12. Attebring MF, Hartford M, Hjalmarson A, et al. Smoking habits and predictors of continued smoking in patients with acute coronary syndromes. J Adv Nurs. 2004;46(6):614-623. doi:10.1111/j.1365-2648.2004.03052.x PubMed
13. Spring B, Doran N, Pagoto S, et al. Fluoxetine, smoking, and history of major depression: a randomized controlled trial. J Consult Clin Psychol. 2007;75(1):85-94. doi:10.1037/0022-006X.75.1.85 PubMed
14. Zorick T, Sugar CA, Hellemann G, et al. Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine. Drug Alcohol Depend. 2011;118(2-3):500-503. doi:10.1016/j.drugalcdep.2011.04.015 PubMed
15. Pettinati HM. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes. J Clin Psychiatry. 2001;62(suppl 20):26-31. PubMed
16. Kranzler HR, Armeli S, Tennen H, et al. A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype. J Clin Psychopharmacol. 2011;31(1):22-30. doi:10.1097/JCP.0b013e31820465fa PubMed
17. Shoptaw S, Huber A, Peck J, et al. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2006;85(1):12-18. doi:10.1016/j.drugalcdep.2006.03.005 PubMed
18. Winstanley EL, Bigelow GE, Silverman K, et al. A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadonemaintained patients. J Subst Abuse Treat. 2011;40(3):255-264. doi:10.1016/j.jsat.2010.11.010 PubMed
19. Beck A, Steer R. Manual for BDI-II. San Antonio, TX: Psychological Corporation; 1996.
20. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3(3-4):235-241. doi:10.1016/0306-4603(78)90024-2 PubMed
21. Fagiolini A, Comandini A, Catena Dell'Osso M, et al. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012;26(12):1033-1049. doi:10.1007/s40263-012-0010-5 PubMed
22. Dundon W, Lynch KG, Pettinati HM, et al. Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy. Alcohol Clin Exp Res. 2004;28(7):1065-1073. doi:10.1097/01.ALC.0000130974.50563.04 PubMed
23. Pettinati HM, Volpicelli JR, Kranzler HR, et al. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res. 2000;24(7):1041-1049. doi:10.1111/j.1530-0277.2000.tb04648.x PubMed
24. Saules KK, Schuh LM, Arfken CL, et al. Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy. Am J Addict. 2004;13(5):438-446. doi:10.1080/10550490490512762 PubMed